BEYOND BIO

비욘드바이오

Daejeon, South Korea · Founded 2013

Headquarters
Daejeon
Employees
1–10
Founded
2013
Business Model
B2B
Last Round
Venture Round
Rounds
1

About

BeyondBio Inc. is a South Korean biopharmaceutical company founded in 2013 and headquartered in Daejeon, specializing in the R&D of first-in-class small molecule drugs for diseases with high unmet medical needs. The company's pipeline targets pancreatic cancer, colorectal cancer, glioblastoma, blood cancer, lung cancer, and Alzheimer's disease, with lead candidates including BEY1107 (anticancer) and BEY2153, a novel dual-targeting anti-Alzheimer's drug candidate addressing both amyloid and tau proteins. BeyondBio has raised approximately $14.5M and aims to develop innovative therapies that overcome limitations of existing treatments.

Summary

BEYOND BIO is a Biotech company based in Daejeon, South Korea, founded in 2013. Investors include KB Investment.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture Round

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

BEYOND BIO on Indexed.vc
<a href="https://indexed.vc/companies/beyond-bio"><img src="https://indexed.vc/api/badge/company/beyond-bio" alt="BEYOND BIO on Indexed.vc" width="260" height="76" /></a>